Considerations for cancer immunotherapy biomarker research during COVID-19
Carlisle J, Jansen C, Bilen M, Kissick H. Considerations for cancer immunotherapy biomarker research during COVID-19. Endocrine Related Cancer 2020, -1: c1-c8. PMID: 32508308, PMCID: PMC7385701, DOI: 10.1530/erc-20-0187.Peer-Reviewed Original Research